BSEBoard Meeting1d ago · 8 Nov 2026, 05:15 pm

Cian Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve The (Both Standalone and Consolidated) Financial Results for the half-year ended September 30, 2026.

Cian Healthcare Ltd · 542678

✦ AI SummaryResults

Cian Healthcare Ltd has scheduled a Board of Directors meeting on November 13, 2026, to consider and approve the unaudited financial results for the half-year ended September 30, 2026.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Cian Healthcare Ltd - 542678 - Board Meeting Intimation for The Meeting (CIAN/BM/2026-27/03) Of The Board Of Directors, Scheduled To Be Held On Friday, November 13, 2026.

Attachments (1)

📄

52ba6b7d-735d-4918-a45d-5ef07b0b81ab.pdf

pdf

Download →
View document text
Ref. No.: CIAN/BSE/2026-27/32 Sunday, November 08, 2026 The Manager-Listing BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 BSE Scrip Code: 542678 Trading Symbol: CHCL Subject: Intimation regarding the meeting (CIAN/BM/2026-27/03) of the Board of Directors of Cian Healthcare Limited, scheduled to be held on Friday, November 13, 2026. Reference: Intimation made pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”). Dear Sir/Madam, Pursuant to Regulation 29 read with Regulations 30, 33 and other applicable regulations of the Listing Regulations, we, Cian Healthcare Limited (“Company”), wish to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 13, 2026, to inter-alia consider and approve the un-audited (Standalone and Consolidated) financial results of the Company for the half year ended on September 30, 2026. Further, in continuation to our letter vide Ref. No.: CIAN/BSE/2026-27/25 dated September 22, 2026, regarding intimation for closure of Trading Window, pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (as amended) and as per the Prohibition of Insider Trading Code of the Company, the trading window for dealing in securities of the Company is closed for all Designated Persons of the Company and their immediate relatives from October 01, 2026. Further, the trading window shall remain closed up to 48 hours after the declaration of the un-audited (Standalone and Consolidated) financial results. The above-stated intimation is also being submitted in XBRL mode. Kindly take the information on record and oblige. Thanking You For Cian Healthcare Limited Rachit Malhotra Company Secretary and Chief Compliance Officer Membership No.: A39894 Place: New Delhi